Janux Therapeutics (JANX)
(Delayed Data from NSDQ)
$22.83 USD
+0.25 (1.11%)
Updated Aug 8, 2025 04:00 PM ET
After-Market: $22.67 -0.16 (-0.70%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Janux Therapeutics, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
JANX 22.83 +0.25(1.11%)
Will JANX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for JANX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for JANX
JANX Stock Hits Record High on Prostate Cancer Study Data
Janux Therapeutics (JANX) Moves 6.5% Higher: Will This Strength Last?
JANX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for JANX
Buy Rating for Janux Therapeutics Driven by Promising Pipeline and Strong Financial Position
Decoding Janux Therapeutics Inc (JANX): A Strategic SWOT Insight
Janux Therapeutics GAAP EPS of -$0.55
Janux Therapeutics reports Q2 EPS (55c), consensus (47c)
Janux Therapeutics Inc (JANX) Announces First Patient Dosed in Merck Collaboration | JANX stock news